McClurg Ronald W. 4
4 · NEUROONE MEDICAL TECHNOLOGIES Corp · Filed Apr 25, 2023
Insider Transaction Report
Form 4
McClurg Ronald W.
Chief Financial Officer
Transactions
- Award
Common Stock
2023-04-21+12,500→ 79,500 total - Award
Option to Purchase Common Stock
2023-04-21+12,500→ 12,500 totalExercise: $1.59Exp: 2033-04-20→ Common Stock (12,500 underlying)
Footnotes (2)
- [F1]Represents a grant of restricted stock units, which vest as to 50% of the shares on the first anniversary of the grant date, with the remaining shares vesting in equal quarterly installments on the last day of each quarter over the next 8 quarters, subject to continued service on such vesting date.
- [F2]25% will vest on April 21, 2024 and the remaining 75% will vest in 12 equal quarterly installments on the last day of each quarter beginning on June 30, 2024.